Page 861 - Withrow and MacEwen's Small Animal Clinical Oncology, 6th Edition

Index 839

Subcutaneous tissue, tumor of (Continued) Surgical oncology (Continued) Testosterone, 19
surgery for, 355 for mast cell tumors, 389 Th2 cytokine, production of, 334
reexcision of, 390f
tumor grading for, 355
Thalidomide, human multiple myeloma and,
VetBooks.ir Sublethal radiation damage/repair, 214 for melanoma, 369–370 T-helper 1 (Th1), 334
264–265
Submandibular salivary gland, aspiration of,
miscellaneous, 171
129–130 radiation therapy and, 170 Therapeutic gain, 182–183
Substance P, 298–299 Survival, with feline sarcoma, 424 Therapeutic index, 182–183
Substrate Survival-promoting signal transduction Therapeutic irradiation, 16
for cancer bearing patient, 306–308 cascade, 53 Thermal injury, 352
for parenteral nutrition, 305–306 Survivin, 533 Third eyelid adenocarcinoma, 675–676
Subungual undifferentiated MCT, 386–387, Surviving fraction, after radiation therapy, 214 Third eyelid tumor, 675–678
386f Swiss Cancer Registry, 83t clinical signs of, 676–677
Sudan black B, 129 Synovial cell sarcoma, cell characteristics in, diagnostic techniques and workup, 677
Suicide gene 141 history of, 676–677
cancer cell destruction by, 255 Syringe feeding, 304–305 incidence of, 675, 676f–677f
stem cells to deliver, 256 Systematic error, 86 natural behavior of, 675–676
Summarizing, in communication, 315 observational studies and, 86 pathology of, 675–676
Sunitinib (Sutent), 262 Systemic histiocytosis, 792t prognosis for, 677–678
Sunlight, 16 Systemic mastocytosis, 383 risk factors for, 675
observational studies for cancer from, subtypes of, 397 therapy for, 677–678
87t–91t Thoracic radiography, 114f
Superficial keratectomy/sclerectomy, for ocular T for intestinal tumors, 464
tumors, 678 T cell, 148 Thoracoscopy, 161
Superficial necrolytic dermatitis TAM. see Tumor-associated macrophages Thorax, laparoscopic/thoracoscopic biopsy
characteristics of, 105 Targeted gene delivery of, 161
tumors associated with, 99b transcriptional, 254 Thrombocytopenia
Superficial squamous cell carcinoma, 169–170 transductional, 253 causes of, 103
Supportive care, for cancer patient, 286–329 Targeting angiogenesis, 264–265 treatment of, 104
Surgery Targeting lymphangiogenesis, 263 tumors associated with, 99b
for canine insulinoma, 583–584 TAs. see Tumor antigens Thrombospondin-1 (TSP-1), 47–48
for canine osteosarcoma, 534–538, 535t Taxane (paclitaxel and docetaxel), 195 Thrombospondin-1 mimetic peptide, 264
for canine pituitary-dependent TCC. see Transitional cell carcinoma Thymic carcinoma, 135–136
hypercortisolism, 567–568 T-cell leukemia, 26 Thymidine, 119–121
for feline sarcoma, 420–421, 421f–422f T-cell lymphoma Thymidylate synthetase, 184
for intestinal tumor, 465–467, 466f cell characteristics in, 142 Thymoma, 778
for intracranial tumors, 663–664 comparative genomic hybridization and, cell characteristics in, 135–136
for large intestine, 466–467 147 comparative aspects, 780–781
for nasal planum, cancer of, 492–493, 493f fine-needle aspiration of, 143f diagnostic techniques and workup,
for oral tumors, 437, 439t, 440f gene silencing and, 10 779–780, 779f
for skin/subcutaneous tissue tumor, 355 immunohistochemical markers/panels for, fine-needle aspiration of, 136f
for small intestine, 465–466, 466f 72t–73t history and clinical signs, 779
for soft tissue sarcomas, 411–413, with trisomy 15, 269 incidence and risk factors, 778
411f–414f TCHM. see Traditional Chinese herbal pathology and natural behavior, 779
for spinal cord tumors, 668–669 medicine prognosis, 780
for transitional cell carcinoma, 648–649 TECA. see Total ear canal ablation therapy, 780
Surgical adrenalectomy, for canine Technical error, 75 Thyroid carcinoma
adrenocortical tumors, 572 Teletherapy, 215 CT angiogram of, 3D-reconstructed, 117f
Surgical margin Telomerase, 6 fine-needle aspiration of, 136f
assessment of, 69 activation of, 47 hypercalcemia of malignancy and, 100
inking systems for, 162 complex, 47 scintigraphy of, 120f
for malignant melanoma Telomere, 47, 47f Thyroid gland neoplasia
of caudal dental arcade, 371f Telomeric attrition in cats, 577–580
considerations for, 370 cause of, 47f in dogs, 575–577
of digital webbing, 371f cellular aging and, 46–47 Thyroid scintigraphy, for feline
width of, 167 cellular senescence and, 47f hyperthyroidism, 578
Surgical oncology, 164–173 Telophase, 36 Thyroid tumor, immunohistochemical
cancer management by, 164 Teniposide, 196 markers/panels for, 72t–73t
chemotherapy and, 170 Teratoma, 598 Tie-1/Tie-2, 258
cytoreductive, 169 TERT expression, 627–628 Time
for diagnosis, 164 Testicle radiation therapy and, 211–212
lymph node removal and, 168 as echogenic and cavitated, 629f repopulation of normal tissue, 213–214
for malignant cancer, 167 with echogenic neoplastic nodule, 630f stereotactic radiation therapy and, 213–214